Tag:
Logical Therapeutics
Latest Headlines
Latest Headlines
Logical Therapeutics closes $16.9M round for NSAID program
After disclosing recently that it had landed the first $10 million of a Series C, Logical Therapeutics today announced that it has closed its $16.9 million round, with SV Life Sciences leading a
Logical Therapeutics raises cash for mid-stage NSAID trial
Logical Therapeutics has pulled in the first $10 million in a planned $16.9 million round, according to Xconomy, citing documents filed with the Securities and Exchange Commission. The company's
